Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Essential Healthcare News.
Press releases published on September 28, 2025
Startups from Turkey and Israel Shine Bright at EthAum’s Global ‘Healthcare Innovation Pitches’
SINGAPORE, SINGAPORE, SINGAPORE, September 28, 2025 /EINPresswire.com/ -- In a world where healthcare challenges know no borders, neither does innovation. EthAum Venture Partners (https://ethaum.com/), a deep tech accelerator based in Singapore, recently …
Health City Cayman Islands Rebrands Flagship Youth Program as Health City Explorers
CAYMAN ISLANDS, September 28, 2025 /EINPresswire.com/ -- Health City Cayman Islands has rebranded its flagship youth program, Healthcare Explorers, as Health City Explorers to strengthen the program’s connection to the internationally recognized medical …
Rhino Rescue Launches St. Bernard, a New Brand for Children’s First Aid and Safety
WUXI, JIANGSU, CHINA, September 28, 2025 /EINPresswire.com/ -- Rhino Rescue today announced the launch of St. Bernard, a new sub-brand dedicated to children’s and pet safety. The brand introduces a line of child-friendly first aid kits and family …
Avare Biotech Launches World’s First AI-Powered Mobile App for Livestock Semen Analysis
Revolutionizing animal reproduction with accessible, affordable, and instant semen quality assessment DUBAI, UNITED ARAB EMIRATES, September 28, 2025 /EINPresswire.com/ -- Avare Biotech, a Dubai-based animal health innovator, announced the launch of its …
“LEQEMBI®” (lecanemab) IV Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Approved in China
1. About LEQEMBI (generic name: lecanemab, Chinese brand name: 乐意保) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma (IgG1) monoclonal antibody directed against aggregated soluble …
Larimar Therapeutics Announces Conference Call on the Nomlabofusp Program for the Treatment of Friedreich’s Ataxia
BALA CYNWYD, Pa., Sept. 28, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (Larimar) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced that the Company will host a …
MoonLake Immunotherapeutics reports on week 16 results of the VELA Phase 3 hidradenitis suppurativa program with the Nanobody® sonelokimab
VELA-1 and VELA-2 are two identical trials to evaluate the efficacy and safety of sonelokimab in adult participants with moderate to severe hidradenitis suppurativa (HS) and the first Phase 3 program using the higher clinical response level of HS Clinical …
Acoramidis Begins to Reduce Cumulative Cardiovascular Outcomes Within the First Month of Treatment in Patients with ATTR-CM
- By Month 1, numerically fewer cumulative events were observed with acoramidis compared to placebo - Acoramidis significantly reduced the cumulative risk of CVM or recurrent CVH through Month 30 versus placebo with a 49% hazard reduction (p<0.0001) - The …
Dental Camp Visit at Modi Vanik Samaj: Celebrating Service and Spreading Oral Health Awareness
Free dental check-ups, awareness sessions, and community support marked the healthcare camp at Modi Vanik Samaj, honoring PM Modi’s 75th birthday. SURAT, GUJARAT, INDIA, September 28, 2025 /EINPresswire.com/ -- On 14th September 2025, a remarkable …
Silent Strain: New Data Shows Men in Their 40's Facing Unprecedented Mental Health Crisis
New data reveals midlife men face record levels of stress, loneliness, and health risks—sparking urgent calls for mental health solutions SAN DIEGO, CA, UNITED STATES, September 28, 2025 /EINPresswire.com/ -- A CRISIS IN THE SHADOWS Men across …